Document is current

Article History

Received: 2 February 2024

Accepted: 17 July 2024

First Online: 22 July 2024

Competing interests

: AA, IMC, AAH, SM, BG, JS, MP, and TAG were employed at nQ Medical Inc. and received a regular salary while contributing to the work. YU, AK and TY were employed at Mitsubishi Tanabe Pharma Corporation and received a regular salary while contributing to the work. SI was employed at Mitsubishi Tanabe Pharma America, Inc. and received a regular salary while contributing to the work. AL was a contractor for Mitsubishi Tanabe Pharma America, Inc. and received a salary while contributing to the work. SAJ reports research support from the ALS Association. JDB has received research support from Biogen, Mitsubishi Tanabe Pharma America, Inc., Transposon Therapeutics, Alexion, Rapa Therapeutics, ALS Association, Muscular Dystrophy Association, ALS One, Tambourine, ALS Finding a Cure. He has been a paid member of an advisory panel for Regeneron, Biogen, Clene Nanomedicine, Mitsubishi Tanabe Pharma America, Inc., Janssen, RRT. He received an honorarium for an educational event for Projects in Knowledge. He has unpaid roles on the advisory boards for the non-profits Everything ALS and ALS One. Other authors declare that they have no conflict of interest.